Cite
HARVARD Citation
Nef, H. et al. (2018). A multicenter post‐marketing evaluation of the Elixir DESolve® Novolimus‐eluting bioresorbable coronary scaffold system: First results from the DESolve PMCF study. Catheterization and cardiovascular interventions. 92 (6), pp. 1021-1027. [Online].